...
首页> 外文期刊>World Journal of Gastroenterology >Thiopurine-methyltransferase variants in inflammatory bowel disease: Prevalence and toxicity in Brazilian patients
【24h】

Thiopurine-methyltransferase variants in inflammatory bowel disease: Prevalence and toxicity in Brazilian patients

机译:炎症性肠病中的硫嘌呤-甲基转移酶变异体:巴西患者的患病率和毒性

获取原文

摘要

AIM: To analyze the prevalence of thiopurine-methyltransferase (TPMT) genotypes and their association with drug toxicity in inflammatory bowel disease (IBD) patients from southeastern Brazil. METHODS: A total of 219 consecutive patients with IBD, of which 146 had Crohn’s disease and 73 had ulcerative colitis, regularly seen at the outpatient unit of the Division of Gastroenterology at the University Hospital Pedro Ernesto of the State University of Rio de Janeiro, a tertiary referral center, were enrolled in this study from February 2009 to January 2011. We analyzed the presence of major TPMT genetic variants (TPMT*2, *3A, *3C) in IBD patients by means of a specific allele and RFLP-PCR. Genomic DNA was isolated from peripheral blood leukocytes by proteinase-K/Sodium Dodecyl Sulfate digestion and phenol-chloroform extraction. TPMT*2 (C238G), TPMT*3A (G460A/A719G), and TPMT*3C (A719G) genotypes were detected by real-time polymerase chain reaction followed by direct sequencing with specific primers. Clinical data were systematically recorded, and correlated with the genotype results. RESULTS: The distribution of the selected TPMT gene polymorphism TPMT*2 (C238G), TPMT*3A (G460A/A719G), and TPMT*3C (A719G) genotypes was 3.6%, 5.4%, and 7.7% of the patients, respectively. Among the side effects recorded from patients taking azathioprine, 14 patients presented with pancreatitis and/or an elevation of pancreatic enzymes, while 6 patients had liver toxicity, and 2 patients exhibited myelosuppressioneutropenia. TPMT polymorphisms were detected in 37/219 patients (8 heterozygous for *2, 11 heterozygous for *3A, and 18 heterozygous for *3C). No homozygotic polymorphisms were found. Despite the prevalence of the TPMT*3C genotype, no differences among the genotype frequencies were significant. Although no association was detected regarding myelotoxicity or hepatotoxicity, a trend towards the elevation of pancreatic enzymes was observed for TPMT*2 and TPMT*3C genotypes. CONCLUSION: The prevalence of TPMT genotypes was high among Brazilian patients. Variants genes *2 and *3C may be associated with azathioprine pancreatic toxicity in a IBD southeastern Brazilian population.
机译:目的:分析巴西东南部炎性肠病(IBD)患者中硫嘌呤-甲基转移酶(TPMT)基因型的流行及其与药物毒性的关系。方法:在里约热内卢州立大学佩德罗·埃内斯托大学医院消化内科定期门诊定期检查的219例连续IBD患者,其中146例患有克罗恩病,73例患有溃疡性结肠炎。第三推荐中心于2009年2月至2011年1月参加了这项研究。我们通过特定等位基因和RFLP-PCR分析了IBD患者中主要TPMT遗传变异(TPMT * 2,* 3A,* 3C)的存在。通过蛋白酶K /十二烷基硫酸钠消化和苯酚-氯仿提取从外周血白细胞中分离基因组DNA。 TPMT * 2(C238G),TPMT * 3A(G460A / A719G)和TPMT * 3C(A719G)基因型是通过实时聚合酶链反应,然后使用特异性引物直接测序来检测的。系统地记录临床数据,并将其与基因型结果相关联。结果:选择的TPMT基因多态性TPMT * 2(C238G),TPMT * 3A(G460A / A719G)和TPMT * 3C(A719G)基因型的分布分别为患者的3.6%,5.4%和7.7%。在服用硫唑嘌呤的患者记录的副作用中,有14例出现胰腺炎和/或胰腺酶升高,而6例有肝毒性,而2例表现出骨髓抑制/中性粒细胞减少。在37/219位患者中检测到TPMT多态性(* 2为8个杂合,* 3A为11个杂合,* 3C为18个杂合)。没有发现纯合子多态性。尽管TPMT * 3C基因型盛行,但基因型频率之间没有显着差异。尽管未检测到骨髓毒性或肝毒性的相关性,但对于TPMT * 2和TPMT * 3C基因型,观察到了胰腺酶升高的趋势。结论:巴西患者中TPMT基因型的患病率较高。在巴西东南部的IBD人群中,变异基因* 2和* 3C可能与硫唑嘌呤对胰腺的毒性有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号